Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Selzentry (maraviroc) 150 mg, and 300 mg tablets
Company: Pfizer, Inc.
NDA: 022128
Approval Date: 8/6/2007

 

Date created: January 5, 2009

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-